Clinical Outcomes in Patients With CLL With and Without del(17p) Receiving First-Line Ibrutinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Haematologica
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib
Haematologica 2022 Apr 21;[EPub Ahead of Print], AR Mato, B Tang, S Azmi, K Yang, X Zhang, JC Stern, E Hedrick, J Huang, JP SharmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.